Quintiles Transitional Holdings Inc. (NYSE:Q) was upgraded by equities researchers at Stifel Nicolaus from a “hold” rating to a “buy” rating in a note issued to investors on Friday, October 27th, Marketbeat.com reports. The brokerage presently has a $128.00 price objective on the medical research company’s stock, up from their prior price objective of $92.00. Stifel Nicolaus’ target price points to a potential upside of 23.02% from the stock’s previous close.
Q has been the subject of a number of other research reports. BidaskClub lowered Quintiles Transitional Holdings from a “strong-buy” rating to a “buy” rating in a research note on Friday, August 11th. Jefferies Group LLC reiterated a “hold” rating and set a $94.00 price objective on shares of Quintiles Transitional Holdings in a research note on Friday, August 4th. William Blair upgraded Quintiles Transitional Holdings from a “market perform” rating to an “outperform” rating and boosted their target price for the stock from $70.10 to $93.42 in a report on Friday, August 4th. Citigroup Inc. upped their price objective on Quintiles Transitional Holdings from $96.00 to $97.00 and gave the company a “neutral” rating in a report on Monday, August 7th. Finally, Barclays PLC set a $100.00 price objective on Quintiles Transitional Holdings and gave the company a “buy” rating in a report on Friday, August 4th. Eleven equities research analysts have rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the stock. Quintiles Transitional Holdings has an average rating of “Buy” and an average target price of $103.15.
Quintiles Transitional Holdings (NYSE:Q) traded up $0.54 during trading on Friday, reaching $104.05. The company had a trading volume of 1,138,100 shares, compared to its average volume of 1,501,350. The stock has a market capitalization of $21,873.06, a PE ratio of 23.63, a PEG ratio of 1.72 and a beta of 0.65. The company has a debt-to-equity ratio of 1.29, a quick ratio of 1.22 and a current ratio of 1.22. Quintiles Transitional Holdings has a 12 month low of $71.90 and a 12 month high of $110.67.
Quintiles Transitional Holdings (NYSE:Q) last announced its quarterly earnings results on Thursday, October 26th. The medical research company reported $1.19 EPS for the quarter, beating analysts’ consensus estimates of $1.14 by $0.05. Quintiles Transitional Holdings had a return on equity of 12.60% and a net margin of 0.58%. The company had revenue of $2.02 billion during the quarter, compared to analyst estimates of $2.01 billion. During the same period in the prior year, the company earned $1.00 earnings per share. The firm’s revenue was up 77.6% on a year-over-year basis. equities research analysts anticipate that Quintiles Transitional Holdings will post 4.62 EPS for the current fiscal year.
COPYRIGHT VIOLATION WARNING: This piece was published by StockNewsTimes and is the sole property of of StockNewsTimes. If you are accessing this piece on another website, it was illegally copied and reposted in violation of international trademark & copyright legislation. The correct version of this piece can be accessed at https://stocknewstimes.com/2017/11/11/quintiles-transitional-holdings-inc-q-upgraded-to-buy-by-stifel-nicolaus.html.
In other news, insider James H. Erlinger III sold 10,000 shares of the firm’s stock in a transaction that occurred on Wednesday, September 27th. The shares were sold at an average price of $94.52, for a total transaction of $945,200.00. Following the completion of the transaction, the insider now directly owns 27,340 shares of the company’s stock, valued at approximately $2,584,176.80. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Jack M. Greenberg sold 33,400 shares of the firm’s stock in a transaction that occurred on Monday, November 6th. The stock was sold at an average price of $108.07, for a total transaction of $3,609,538.00. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 14,175,702 shares of company stock valued at $1,361,299,848. 6.40% of the stock is currently owned by corporate insiders.
Hedge funds and other institutional investors have recently made changes to their positions in the stock. Janus Henderson Group PLC boosted its holdings in shares of Quintiles Transitional Holdings by 33,092.0% in the 2nd quarter. Janus Henderson Group PLC now owns 6,531,857 shares of the medical research company’s stock valued at $584,601,000 after purchasing an additional 6,512,178 shares during the last quarter. Glenview Capital Management LLC boosted its holdings in shares of Quintiles Transitional Holdings by 29.3% in the 2nd quarter. Glenview Capital Management LLC now owns 8,921,356 shares of the medical research company’s stock valued at $798,461,000 after purchasing an additional 2,023,719 shares during the last quarter. Royal Bank of Canada boosted its holdings in shares of Quintiles Transitional Holdings by 103.8% in the 2nd quarter. Royal Bank of Canada now owns 59,335 shares of the medical research company’s stock valued at $5,310,000 after purchasing an additional 1,601,888 shares during the last quarter. Discovery Capital Management LLC CT acquired a new position in shares of Quintiles Transitional Holdings in the 2nd quarter valued at $95,228,000. Finally, Laurion Capital Management LP acquired a new position in shares of Quintiles Transitional Holdings in the 2nd quarter valued at $54,510,000. Hedge funds and other institutional investors own 93.29% of the company’s stock.
About Quintiles Transitional Holdings
Quintiles IMS Holdings, Inc, formerly Quintiles Transnational Holdings Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.
Receive News & Ratings for Quintiles Transitional Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quintiles Transitional Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.